Viewing StudyNCT00046371



Ignite Creation Date: 2024-05-05 @ 11:27 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00046371
Status: COMPLETED
Last Update Posted: 2008-01-23
First Post: 2002-09-27

Brief Title: Safety and Immunological Response Rate Study of THERATOPE Vaccine in Metastatic Breast Cancer Patients
Sponsor: Oncothyreon Canada Inc
Organization: Oncothyreon Canada Inc

Conditions & Keywords Data

Conditions:
Name
Breast Neoplasms
Keywords:
Name View
Receptors Progesterone View
Cancer Vaccines View
Aromatase View
Receptors Estrogen View